ADC Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADCT and other ETFs, options, and stocks.About ADCT
ADC Therapeutics SA is a clinical-stage biotechnology company, which engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602.
ADCT Key Statistics
Stock Snapshot
As of today, ADC Therapeutics(ADCT) shares are valued at $1.02. The company's market cap stands at 126.97M, with a P/E ratio of -1.50.
On 2026-08-23, ADC Therapeutics(ADCT) stock traded between a low of $0.97 and a high of $1.02. Shares are currently priced at $1.02, which is +5.4% above the low and 0.0% below the high.
The ADC Therapeutics(ADCT)'s current trading volume is 1.09M, compared to an average daily volume of 1.79M.
In the last year, ADC Therapeutics(ADCT) shares hit a 52-week high of $4.98 and a 52-week low of $0.78.
In the last year, ADC Therapeutics(ADCT) shares hit a 52-week high of $4.98 and a 52-week low of $0.78.
Analyst ratings
50%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.